Assessment of a french Endocrinologist electronic medical Record database for use In observational Studies

Abstract

requiring medical assistance (DC= 6.0, DT= 5.9), HE requiring non-medical assistance (DC= 5.9, DT= 5.9), other HE not requiring assistance (DT= 5.7), and treatment goals not being met (DC= 5.6). Compared to current users, DT and DC patients were more likely to have experienced ≥ 1 HE in the previous year (DC= 41.0%, DT= 43.1% vs. current= 8.8%; p< .05), and experienced a greater mean number of events per year (DC= 1.59, DT= 1.47 vs. current= 0.24, p< .05). Having ≥ 1 HE requiring medical assistance in the previous year was more common among DC patients than DT or current patients (DC= 7.4%, DT= 4.3%, current= 4.8%; p< .05). CONCLUSIONS: Hypoglycemia and glycemic control emerged as the most important concerns physicians have when deciding to DC or DT SU therapy. DC and DT patients were more likely to have experienced HE, and with greater severity, than current SU patients.